Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,562 | -15,844 | -17,051 | -108,779 | -58,289 |
| Depreciation Amortization | 5,485 | 7,322 | 9,374 | 85,478 | 21,982 |
| Accounts receivable | -7,629 | 5,201 | -7,153 | 6,533 | 1,544 |
| Accounts payable and accrued liabilities | 287 | -2,076 | 2,384 | N/A | N/A |
| Other Working Capital | -5,733 | -4,660 | -5,799 | -10,863 | 1,681 |
| Other Operating Activity | 19,215 | 8,669 | 13,116 | -1,192 | 7,118 |
| Operating Cash Flow | $-1,937 | $-1,388 | $-5,129 | $-28,823 | $-25,964 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 440 | -329 | N/A | N/A | -2,341 |
| Net Acquisitions | -3,000 | N/A | N/A | N/A | 202 |
| Other Investing Activity | 0 | 0 | -117 | -3,248 | -643 |
| Investing Cash Flow | $-2,560 | $-329 | $-117 | $-3,248 | $-2,782 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,668 | 832 | -2,250 | N/A | 51,206 |
| Debt Issued | 1,857 | 13,000 | N/A | 15,000 | 0 |
| Debt Repayment | -7,873 | -18,288 | -4,362 | -20,510 | -7,056 |
| Common Stock Issued | 14,840 | 3,467 | 15,575 | 11,694 | 40,148 |
| Other Financing Activity | -49 | -273 | -92 | -4,654 | -53,984 |
| Financing Cash Flow | $15,443 | $-1,262 | $8,871 | $1,530 | $30,314 |
| Beginning Cash Position | 20,006 | 22,985 | 19,360 | 49,901 | 48,333 |
| End Cash Position | 30,952 | 20,006 | 22,985 | 19,360 | 49,901 |
| Net Cash Flow | $10,946 | $-2,979 | $3,625 | $-30,541 | $1,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,937 | -1,388 | -5,129 | -28,823 | -25,964 |
| Capital Expenditure | -228 | -329 | N/A | N/A | -2,341 |
| Free Cash Flow | -2,165 | -1,717 | -5,129 | -28,823 | -28,305 |